arrow
L

Luciano F. Drager

Universidade de São Paulo
H指数:61
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale , design and baseline characteristics of the OPTIMAL-DIABETES randomized trial

强化血压控制以预防2型糖尿病患者主要心血管事件:OPTIMAL-DIABETES随机试验的原理、设计与基线特征

2026-08-010
PRE
Somatic Drivers in Aldosterone-producing Adenomas and Nodules: Insights from a Brazilian Cohort of Primary Aldosteronism

醛固酮分泌腺瘤和结节中的体细胞驱动基因:来自巴西原发性醛固酮增多症队列的见解

2026-01-011
PRE
2025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies

2025年巴西基于证据的肥胖管理及心血管疾病预防和肥胖相关并发症预防指南:五家医学学会的立场声明

2025-11-190
OAAI
Industry sponsorship bias in randomized controlled trials of digital cognitive behavioral therapy for insomnia: a meta-research study based on the 2023 Brazilian guidelines on the diagnosis and treatment of insomnia in adults

数字认知行为疗法治疗失眠的随机对照试验中的行业赞助偏倚:一项基于2023年巴西成人失眠诊断和治疗指南的元研究

2025-07-230
OA
Discrepancies between office and home blood pressure targets in patients with hypertension according to the 2024 European Society of Cardiology Hypertension Guidelines

根据2024年欧洲心脏病学会高血压指南,高血压患者办公室与家庭血压目标之间的差异

2025-04-090
PRE
Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: Design and rationale of the CARDIOTOX trial
2025-02-010
OAAI
Adrenal Venous Sampling Using Metanephrine in Primary Aldosteronism With or Without Cortisol Cosecretion
2024-12-260
OA
Association Between Papillary Thyroid Cancer and Primary Aldosteronism in Individuals With Hypertension
2024-09-182
OA